| Literature DB >> 23676125 |
Soodabeh Saeidnia1, Ahmad Reza Gohari, Azita Haddadi.
Abstract
Human trypanosomiasis is a parasitic disease among poor people in Africa and Latin America. Therapy against African and American trypanosomiasis is based on a few drugs that often cause severe side-effects. Therefore, it is essential to develop drug discovery especially from natural origins. Sesquiterpenes, a diverse group of natural terpenoids, are found in essential oils of many plants and show a broad range of bioactivities. They act through multiple mechanisms in the chemotherapy of trypanosomiasis. Some of these active compounds contain hydroperoxides, aldehydes, alcohols, α,β-unsaturated γ-lactone and even halogenated moieties. Among the compounds reported, sesquiterpene lactones showed a potent anti-trypanosoma effect comparable with commercial trypanocidal drugs. Trypanocidal activity of sesquiterpene lactones mostly depends on the reaction between γ-lactone moieties and nucleophile groups of trypanithione, which is essential for Trypanosoma defense against the oxidative stresses. Elatol is a sesquiterpenoid from marine algae, with a different structure and considerable trypanocidal activity which could be an interesting candidate for further antiprotozoal investigations. To develop novel drugs with higher efficacy and lower toxicity from natural products, this review summarizes the more recent information on trypanocidal activities of various sesquiterpenes.Entities:
Year: 2013 PMID: 23676125 PMCID: PMC3663703 DOI: 10.1186/2008-2231-21-35
Source DB: PubMed Journal: Daru ISSN: 1560-8115 Impact factor: 3.117
Figure 1Chemical structures of trypanocidal sesquiterpene hydroperoxides.
Figure 2Chemical structures of trypanocidal sesquiterpene lactones.
Figure 3Structures of various trypanocidal secoaromadendrane, caryophyllene, drimane and coloratane aldehyde types together with elatol.
Figure 4A schematic mechanism of action for trypanocidal sesquiterpenes.
The related MIC and/or ICof the active sesquiterpene compounds againstand
| 1 | 0.84 | | | [ |
| 2 | 1.7 | | | [ |
| 3 | 1.7 | | | [ |
| 4 | >200 | | | [ |
| 5 | | 0.6(E); 3.5(T); 0.9(A) | | [ |
| 6 | | 3.8 ± 0.19 parasite | | [ |
| 7 | | 1.9 ± 0.08 parasite | | [ |
| 9 | | 21.7(T) | 4.5(T) | [ |
| 10 | | >90.0(T) | 7.7(T) | [ |
| 11 | | | 11.3(T) | [ |
| 12 | | 6.3 ± 0.25(E)* | | [ |
| | | 4.9 ± 0.42(T)* | | |
| 13,14 | | 11.7 ± 0.99(E)* | | [ |
| | | 6.1 ± 0.60(T)* | | |
| 15 | 240** | | | [ |
| 16 | 150** | | | [ |
| 17 | 3600** | | | [ |
| 18 | | 14.8(T) | | [ |
| 19 | | 13.2(T) | | [ |
| 20 | | 449.6(T) | | [ |
| 21 | | 1029.0(T) | | [ |
| 22 | | | 0.56(T) | [ |
| 23 | | | 1.25(T) | [ |
| 24 | | | 0.64(T) | [ |
| 25 | | | 6.4(T) | [ |
| 26 | 45.4(E);1.38(T);1.01(A) | [ |
*IC90; ** MIC. A: amastigote; E: epimastigote; T: trypomastigote.